The 11-year long-term follow-up study from the randomized BENEFIT CIS trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

Published:2016-08-10 Issue:10 Volume:87 Page:978-987
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Kappos Ludwig,Edan Gilles,Freedman Mark S.,Montalbán Xavier,Hartung Hans-Peter,Hemmer Bernhard,Fox Edward J.,Barkhof Frederik,Schippling Sven,Schulze Andrea,Pleimes Dirk,Pohl Christoph,Sandbrink Rupert,Suarez Gustavo,Wicklein Eva-Maria,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High socioeconomic impact on prescription behavior despite unrestricted access to disease-modifying therapies in people with multiple sclerosis;Frontiers in Immunology;2024-08-15

2. Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trial;Journal of Neurology;2024-05-10

3. Shifting our attention earlier in the multiple sclerosis disease course;Current Opinion in Neurology;2024-03-28

4. Documento de consenso de la Sociedad Española de Neurología sobre el tratamiento de la esclerosis múltiple y manejo holístico del paciente 2023;Neurología;2024-03

5. Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023;Neurología (English Edition);2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP